Piramal Pharma to invest USD 90M in expansion of two US sites Ruchika Sharma13 May 2025 11:28 AM ISTMumbai: Piramal Pharma Limited, a global pharmaceuticals and wellness company, in conjunction with the 2025 Select USA Investment Summit,...
Piramal Pharma Turbhe facility gets USFDA EIR Ruchika Sharma12 May 2025 4:47 PM ISTMumbai: Piramal Pharma has informed in a BSE filing that the US Food and Drug and Administration (USFDA) has issued an Establishment Inspection Report...
Piramal Pharma begins Sevoflurane commercial production at Digwal facility Ruchika Sharma2 April 2025 12:15 PM ISTMumbai: Piramal Pharma Limited has announced the commencement of commercial production of Sevoflurane at the Company’s facility located at Digwal,...
USFDA issues 6 observations for Piramal Pharma Turbhe facility Ruchika Sharma19 Feb 2025 12:30 PM ISTMumbai: Piramal Pharma has announced that the Company has received six observations from US Food and Drug Administration (USFDA) at the...
Piramal Critical Care launches Chlorpromazine Hydrochloride for Injection in US Ruchika Sharma23 Jan 2025 12:15 PM ISTBethlehem: Piramal Critical Care (PCC), a division of Piramal Pharma Limited has announced the U.S. launch of Chlorpromazine Hydrochloride for...
Piramal Pharma appoints Sai Ramana Ponugoti as CEO, India Consumer Healthcare Ruchika Sharma7 Jan 2025 5:24 PM ISTMumbai: Piramal Pharma has appointed Sai Ramana Ponugoti as Chief Executive Officer ('CEO') India Consumer Healthcare ('ICH') (Senior Management...
Piramal Pharma to pay USD 407400 to resolve dispute with VetDC Ruchika Sharma7 Dec 2024 3:28 PM ISTMumbai: Through a recent BSE filing, Piramal Pharma has informed that it has agreed to pay USD 407,400 to US-based VetDC, Inc to settle a dispute over...
Piramal Pharma deploying USD 85 million capex this fiscal: Nandini Piramal Ruchika Sharma28 Oct 2024 2:15 PM ISTNew Delhi: A capex of about USD 85 million is being utilized by Mumbai-headquartered company, Piramal Pharma, for various initiatives, including...
Piramal Pharma Reports Over Fourfold Surge in Q2 Net Profit to Rs 23 Crore, Announces Expansion Plans MD Bureau24 Oct 2024 4:35 PM ISTRevenue from operations rose to Rs 2,242 crore in the second quarter as compared with Rs 1,911 crore in the year-ago period, Piramal Pharma said.
Sarosh Shetty to join Piramal Pharma as Interim - CEO of India Consumer Healthcare business, Nitish Bajaj resigns Ruchika Sharma9 Oct 2024 12:15 PM ISTIn a BSE filing, Piramal Pharma has informed that Nitish Bajaj, Chief Executive Officer, India Consumer Healthcare and a Senior Management Personnel...
Piramal Pharma Solutions plans to expand Lexington facility with USD 80 million investment Ruchika Sharma2 Oct 2024 12:00 PM ISTMumbai: Piramal Pharma Solutions (PPS), a global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd., has...
USFDA issues EIR for Piramal Pharma Ahmedabad facility Ruchika Sharma30 Sept 2024 12:11 PM ISTMumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its...
